Dr. Gilthorpe holds the position of Group Leader in Translational Neuroscience at the Department of Pharmacology and Clinical Neuroscience, Umeå University, Sweden. He has more than 20 years experience in basic and preclinical research and his group focuses on molecular and cellular pathways associated with neural responses to neurotrauma and neurodegeneration.
Jonathan Gilthorpe is from Chesterfield, Derbyshire, UK and graduated from the University of Leeds with First Class Honours in Microbiology/Virology. He completed his Ph.D. in Developmental Biology on the genetic regulation of transcription under the supervisor of Prof. Peter W. J. Rigby FRS at the National Institute for Medical Research, Mill, Hill, London. His postdoctoral career in the UK, USA and Sweden has encompassed many aspects of Neuroscience, from early brain development to circuit formation and neurodegeneration. He worked with Prof. Andrew Lumsden FRS at the United Medical Schools of Guy’s and St. Thomas’ Hospital, London and latterly the MRC Centre for Developmental Neurobiology, King’s College London, working together with Dr. Adrian Pini. He also worked at Stanford University with Prof. Stephen J. Smith. Jonathan moved to Umeå University, Sweden in 2008 to establish an independent research group within the Umeå Centre for Molecular Medicine. In 2011 he took up his current position within the Department of Pharmacology and Clinical Neuroscience where he runs several clinical and preclinical research projects on the molecular and cellular mechanisms of ALS, multiple sclerosis and Alzheimer’s disease.